Search research articles
Contact Us
Filters
Showing results (501-510 of 554) with videos related to
Page
of 56
Sort By:
British Journal of Cancer
|
October 16, 2018
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours
Amit Maity, Rosemarie Mick, Alexander C Huang, et al.
JAMA Oncology
|
November 22, 2019
Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer
Sundeep Agrawal, Naomi B Haas, Mohammadhadi Bagheri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2022
Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial
Funda Meric-Bernstam, Nizar M Tannir, Othon Iliopoulos, et al.
European Urology
|
May 29, 2024
Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial
Primo N Lara, Catherine Tangen, Elisabeth I Heath, et al.
Lancet (London, England)
|
July 31, 2023
Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial
Christopher W Ryan, Catherine M Tangen, Elisabeth I Heath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial
David C Smith, Matthew R Smith, Christopher Sweeney, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 4, 2006
Melanoma
Alan N Houghton, Daniel G Coit, Adil Daud, et al.
Reviews in Fish Biology and Fisheries
|
June 7, 2021
Food for all: designing sustainable and secure future seafood systems
A K Farmery, K Alexander, K Anderson, et al.
Cancer Discovery
|
April 3, 2023
Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T Cell-Intrinsic Dysfunction
In-Young Jung, Robert L Bartoszek, Andrew J Rech, et al.
Prostate Cancer and Prostatic Diseases
|
October 3, 2020
Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide
Naomi B Haas, Michael J LaRiviere, Thomas H Buckingham, et al.
Page
of 56
Search research articles
Search
Showing results (501-510 of 554) with videos related to
Sort By:
Page
of 56
British Journal of Cancer
|
October 16, 2018
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours
Amit Maity, Rosemarie Mick, Alexander C Huang, et al.
JAMA Oncology
|
November 22, 2019
Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer
Sundeep Agrawal, Naomi B Haas, Mohammadhadi Bagheri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2022
Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial
Funda Meric-Bernstam, Nizar M Tannir, Othon Iliopoulos, et al.
European Urology
|
May 29, 2024
Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial
Primo N Lara, Catherine Tangen, Elisabeth I Heath, et al.
Lancet (London, England)
|
July 31, 2023
Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial
Christopher W Ryan, Catherine M Tangen, Elisabeth I Heath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial
David C Smith, Matthew R Smith, Christopher Sweeney, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 4, 2006
Melanoma
Alan N Houghton, Daniel G Coit, Adil Daud, et al.
Reviews in Fish Biology and Fisheries
|
June 7, 2021
Food for all: designing sustainable and secure future seafood systems
A K Farmery, K Alexander, K Anderson, et al.
Cancer Discovery
|
April 3, 2023
Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T Cell-Intrinsic Dysfunction
In-Young Jung, Robert L Bartoszek, Andrew J Rech, et al.
Prostate Cancer and Prostatic Diseases
|
October 3, 2020
Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide
Naomi B Haas, Michael J LaRiviere, Thomas H Buckingham, et al.
Page
of 56